Pharmaxis Ltd's (ASX:PXS) (OTCMKTS:PXSLY) (FRA:UUD) Gary Phillips speaks to Proactive's Andrew Scott following the news it has exported the first shipment of its locally developed and manufactured drug Bronchitol® to the USA. Phillips describes it as a proud and very rare achievement for a home‐ grown pharmaceutical research company.
viewPharmaxis Ltd
Pharmaxis begins exporting its cystic fibrosis drug Bronchitol® to the USA
Quick facts: Pharmaxis Ltd
Price: 0.081 AUD
ASX:PXS
Market: ASX
Market Cap: $32.18 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Pharmaxis Ltd named herein, including the promotion by the Company of Pharmaxis Ltd in any Content on the Site, the Company receives from said...
FOR OUR FULL DISCLAIMER CLICK HEREDeep dive
Pharmaxis transformational Bronchitol FDA approval extends cash runway...
Most read
Health
Emyria appoints global pharmaceutical expert to chair Strategic Advisory Board
4 days, 4 hours ago
Mining
Chalice Mining bolsters board with appointment of highly regarded former Rio...
4 days, 7 hours ago
